|
|
|
||
Last update: Mgr. Alena Vlasáková, DiS. (24.11.2008)
|
|
||
Last update: Mgr. Alena Vlasáková, DiS. (24.11.2008)
Aim of subject is to inform students about antitumor immune response and possibilities of cancer immunotherapy with emphasis on the newest knowledge. |
|
||
Last update: Mgr. Alena Vlasáková, DiS. (24.11.2008)
Journals: Nature Immunology, Nature Cancer Reviews, Cancer Immunol Immunotherapy, Jounal of Immunology, Immunological Reviews, Current Opinion in Immunology, Clinical Cancer Research, Jornal of Controlled Release,... |
|
||
Last update: Mgr. Alena Vlasáková, DiS. (24.11.2008)
lectures and discussions |
|
||
Last update: Mgr. Alena Vlasáková, DiS. (24.11.2008)
Podmínkou získání zápočtu je 10 minutová prezentace na téma související s obsahem kurzu (PowerPoint nebo jen ústní sdělení). Prípustná je jedna absence bez udání důvodu, absence z důvodu nemoce (potvrzení od lékaře)se akceptuje bez jakékoliv formy náhrady. |
|
||
Last update: Mgr. Alena Vlasáková, DiS. (24.11.2008)
1. Cancer etiology (carcinogens, mechanisms of tumor transformation, characteristic features of tumor cells) 2. Tumor antigens, antitumor immune response, tumor escape 3. Possibilities of cancer therapy, history of cancer immunotherapy, methods for immune response monitoring during cancer immunotherapy, vaccine strategies for cancer immunotherapy 4. Cancer immunotherapy with polymer-bound drugs 5. Monoclonal antibodies in cancer immunotherapy (hybridoma technology, chimeric and humanized monoklonal antibodies) 6. Cancer immunotherapy based on the cellular immunity (LAK cells, tumor infiltrating lymphocytes, antigen specific T cells, dendritic cells) 7. Cytokines in cancer immunotherapy, the newest approaches used in cancer immunotherapy 8. Students' presentations |